feed,title,long_url,short_url
Benzinga,"Axsome Therapeutics Rallies 40% On FDA Product Label Proposal, But Analyst Remains Skeptical",https://benzinga.com/analyst-ratings/analyst-color/22/06/27863483/axsome-therapeutics-rallies-40-on-depression-drug-news-but-analyst-remains-skeptica,https://bit.ly/3xV0Eop
